THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Assenagon Asset Management S.A.'s Holding History (CIK: 0001546007)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 404,144 Value ($000) $7,562 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 414,715 Value ($000) $6,055 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 23,980 Value ($000) $264 Avg Close $9.72 Range $7.90 - $11.82

Q1 2024

Shares 40,166 Value ($000) $360 Avg Close $9.27 Range $8.21 - $11.71

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	404,144	$7,562	$16.59	$13.50 - $20.33
Q3 2025	414,715	$6,055	$12.64	$10.82 - $14.87
Q2 2025	23,980	$264	$9.72	$7.90 - $11.82
Q1 2024	40,166	$360	$9.27	$8.21 - $11.71